Charles River Laboratories (CRL) - 12 Year Stock Split History

Historical stock splits for Charles River Laboratories since 2006. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Sector Industry Market Cap Revenue
Medical Medical Services $0.008B $1.858B
Charles River Laboratories International, Inc. provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Their dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. At Charles River, they are passionate about their role in improving the quality of people's lives. Their mission, their excellent science and strong sense of purpose guide in all that they do, and they approach each day with the knowledge that their work helps to improve the health and well-being of many across the globe. Charles River Laboratories International, Inc. service areas are Basic research, discovery, safety and efficacy, clinical support and manufacturing.
Stock Name Country Market Cap PE Ratio
Express Scripts Holding (ESRX) United States $45.460B 10.70
ICON (ICLR) Ireland $7.401B 24.84
PRA Health Sciences (PRAH) United States $6.377B 30.53
INC Research Holdings (SYNH) United States $5.036B 22.17
Premier (PINC) United States $4.978B 20.13
HealthEquity (HQY) United States $4.975B 105.50
Teladoc (TDOC) United States $4.180B 0.00
NovoCure (NVCR) Jersey $3.224B 0.00
AMN Healthcare Services Inc (AMN) United States $2.859B 21.81
Intrexon (XON) United States $1.883B 0.00
BioTelemetry (BEAT) United States $1.613B 44.73
Medpace Holdings (MEDP) United States $1.584B 25.19
IKang Healthcare (KANG) China $1.418B 78.54
Healthways (TVTY) United States $1.412B 20.00
Natera (NTRA) United States $1.241B 0.00
China Cord Blood (CO) China $0.958B 25.61
Apollo Medical Holdings (AMEH) United States $0.801B 0.00
Surgery Partners (SGRY) United States $0.743B 0.00
Civitas Solutions (CIVI) United States $0.590B 15.05
CareDx (CDNA) United States $0.431B 0.00
OncoCyte (OCX) United States $0.114B 0.00
Interpace Diagnostics (IDXG) United States $0.029B 0.00
Cancer Genetics (CGIX) United States $0.024B 0.00
Biocept (BIOC) United States $0.016B 0.00
OpGen (OPGN) United States $0.012B 0.00
FORM Holdings (XSPA) United States $0.008B 0.00